About Cambrian Bioworks
Cambrian Bioworks is a Healthcare company based in Bengaluru (India) founded in 2020 by Rohit Asil, Akshatha Ravi, and Raghav Pooviah Sridhar. It operates as a PCR plate seals, sample preparation, and extraction kits are manufactured. It operates on a HealthTech and Direct-to-Consumer (D2C) model. Cambrian Bioworks has raised $1.45 million across 1 funding round from investors including Vaibhav Hegde and Irani family office. The company has 19 employees. Cambrian Bioworks offers products and services including Manta, Beluga, and Eva. Its focus areas include Biotechnology and Diagnostics. Its legal entity in India is Cambrian Biotech Pvt. Ltd (AAS-6322).
Company details
Innovative technologies are built by Cambrian Bioworks to enable efficient and effective patient care. Focus is placed on advancing diagnostics across sectors like cancer, infectious diseases, genetic screening, and reproductive health. Solutions are provided for molecular workflows, including DNARNA extraction and digital microscopy, supporting labs globally from research to high-throughput facilities.
- Headquarters Bengaluru, India
- Employees 19
- Founders Rohit Asil, Akshatha Ravi, Raghav Pooviah Sridhar
- SectorsHealthcare
- Phone•••• ••••
- Website cambrianbioworks.com
- Social LinkedIn X Instagram YouTube
- Legal Name Cambrian Biotech Pvt. Ltd.
- Date of Incorporation 15 Jun, 2020
- Jurisdiction Bangalore, Karnataka, India
- Total Equity Funding$1.45M (USD)
in 1 rounds
- Latest Funding Round$1.45M (USD), Seed
Aug 2024
- Employee Count19
Associated legal entities of Cambrian Bioworks
Cambrian Bioworks operates through Cambrian Bioworks Llp (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Cambrian Bioworks Llp CIN AAS-6322 | Active | 15 Jun 2020 | Bangalore, Karnataka | – | 40 | 2 | View details |
Products & Services of Cambrian Bioworks
Cambrian Bioworks offers a comprehensive portfolio of products and services, including Manta, Beluga, and Eva.
Efficient DNA/RNA extractions are provided for clinical applications.
Sample-to-result system is offered for seamless nucleic workflows.
Pathology workflows are enhanced with advanced diagnostic technology.
Apps and channels of Cambrian Bioworks
its YouTube channel Cambrian Bioworks has 220 subscribers and 29 videos.
Videos from Cambrian Bioworks
The most watched videos on Cambrian Bioworks's YouTube channel, Cambrian Bioworks (220 subscribers). Click a video to play it here.
More on Cambrian Bioworks.
Funding Insights of Cambrian Bioworks
Cambrian Bioworks has successfully raised a total of $1.45M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.45 million completed in August 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.45M
- Total Rounds 1
- Last Round Seed — $1.45M
- First Round $1.45M
(Aug 2024)
- Investors Count 2
All 1 funding rounds of Cambrian Bioworks with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2024 | $1.45M | Seed | – | Vaibhav Hegde, Irani family office | – |
2 investors in total: 1 institutional and 1 angel.
Investors in Cambrian Bioworks
Cambrian Bioworks has secured backing from 2 investors, including angel and venture fund investors. Prominent investors backing the company include Vaibhav Hegde and Irani family office.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
- | – | iranifamilyoffice.tcc.mode | - | |
VH Vaibhav Hegde | Angel investor and entrepreneur, focused on tech startups, ex-Amazon leader | – | unknown_23a1997812e04bb1b | - |
Investor details for Cambrian Bioworks
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Cambrian Bioworks Llp (Cambrian Bioworks)
Cambrian Bioworks Llp is the primary company behind Cambrian Bioworks. The board of Cambrian Bioworks Llp currently have 2 directors; the longest-serving is Ravigowda Akshatha, appointed in 2020.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ravigowda Akshatha DIN 08751102 | Designated Partner | 15 Jun 2020 | 6 yrs 4 mo | Cambrian Bioworks Llp |
| Mohavi DIN 07980921 | Designated Partner | 15 Jun 2020 | 6 yrs 4 mo | Cambrian Bioworks Llp |
People of Cambrian Bioworks
6 people are tracked at Cambrian Bioworks (4 in leadership, 2 in team); the tracked headcount is 19.
| Name | Role | Group |
|---|---|---|
Rohit Asil | Co-Founder | Leadership |
Akshatha Ravi | Co-Founder | Leadership |
Raghav Pooviah Sridhar | Co-Founder | Leadership |
Vaibhav Hegde | Co-Founder and CEO | Leadership |
Himani Arora | Brand Marketing Manager | Team |
Deeksha Suresh | Product Marketing Manager | Team |
Complete people profiles for Cambrian Bioworks
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Cambrian Bioworks
2 dated milestones of Cambrian Bioworks across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Cambrian Bioworks is founded.
- Funding First funding round of $1.4M.
Top companies in Life Sciences Platforms & Tools
10 companies that operate in the same segment as Cambrian Bioworks (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | 1,111 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Cambrian Bioworks
Cambrian Bioworks was founded in 2020 and raised its 1st funding round 4 years after it was founded.
Cambrian Bioworks is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Cambrian Bioworks is a funded company, having raised a total of $1.45M across 1 funding round to date. The company's 1st funding round was a Seed of $1.45M, raised on Aug 2024.
Cambrian Bioworks has 19 employees.
Innovative technologies are built by Cambrian Bioworks to enable efficient and effective patient care. Focus is placed on advancing diagnostics across sectors like cancer, infectious diseases, genetic screening, and reproductive health. Solutions are provided for molecular workflows, including DNARNA extraction and digital microscopy, supporting labs globally from research to high-throughput facilities.
Cambrian Bioworks offers Manta, Beluga, and Eva.
Cambrian Bioworks has 2 investors. Key investors include Vaibhav Hegde, and Irani family office.
Cambrian Bioworks operates through Cambrian Bioworks Llp.
The legal entities of Cambrian Bioworks currently have 2 directors, including Ravigowda Akshatha, Mohavi.